Description

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration. To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way.The Senior Director, Technical Accounting & SEC Reporting will serve as the company’s subject-matter expert on U.S. GAAP and SEC reporting requirements, partnering closely with Finance leadership, independent auditors, and cross-functional stakeholders to ensure accurate financial reporting and compliance. This role serves as a global steward and owner of accounting policies and will advise on technical accounting considerations and /or requirements as business activities or transactions being contemplated. This leader will own key controls over financial reporting. Role scope will include consolidation of financial results, submission of SEC filings, and underlying systems and research tools. This role will report to the Chief Accounting Officer and partner closely with the CFO, and members of the finance, legal, and HR leadership teams.Key Responsibilities<ul><li>Lead technical accounting assessments for transactions, including:<ul><li>Revenue recognition, collaboration and licensing arrangements</li><li>Stock-based compensation</li><li>Business combinations</li><li>R&D cost accounting, including CRO arrangements and prepaid R&D</li><li>Leases</li></ul></li><li>Draft and maintain technical accounting position papers for global finance team</li><li>Own timely preparation and detailed review of SEC filings (i.e. 10-K, 10-Q, 8-K, DEF 14A), including accounting treatment and disclosures of:<ul><li>MD&A</li><li>Critical accounting estimates</li><li>Revenue</li><li>R&D disclosures (i.e. pipeline acquisitions and IPR&D)</li><li>Licensing, collaboration, and co-commercialization agreements</li><li>EPS</li></ul></li><li>Advise leadership on accounting considerations during deal structuring</li><li>Provide technical accounting guidance to global stakeholders for topics including:<ul><li>Licensing, collaboration, and co-commercialization agreements</li><li>M&A transactions</li><li>Financing and complex capital structures</li></ul></li><li>Provide SEC reporting and technical accounting leadership to the Treasury function on equity and debt offerings, including reviewing offering documents and supporting due-diligence and auditor comfort letter processes</li><li>Partner with Investor Relations to ensure alignment between GAAP and non-GAAP (if applicable) reporting across SEC filings, supplemental reporting, and other investor-facing materials, including investor Q&A</li><li>Articulate issues and recommendations in a crisp and concise manner to both financial and non-financial stakeholders for consideration in decision-making</li><li>Assist in the review of accounting considerations from the execution of significant contracts</li><li>Partner with Legal, FP&A, Tax, Investor Relations on accounting implications of significant transactions and/or ad hoc initiatives</li><li>Co-develop disclosure committee agenda topics with Legal partners</li><li>Perform benchmarking to peer disclosures, review leading disclosure practices for emerging risks, business activities, and newly adopted accounting standards</li></ul>Consolidation of Financial Results<ul><li>Oversee the timely consolidation of financial results, including as needed preparation of journal entries, account reconciliations, and variance analysis</li></ul>Audit & SOX Compliance <ul><li>Serve as primary liaison with independent auditors on technical accounting and audit discussions related to significant non-routine transactions</li><li>Coordinate audit requests, prepare supporting documentation, and resolve audit inquiries for quarterly reviews and annual audits</li><li>Assume ownership for effective key internal controls over financial reporting</li><li>Proactively monitor and operate a robust internal control environment in compliance with Sarbanes-Oxley or similar requirements.</li></ul>Qualifications<ul><li>CPA required</li><li>15+ years of progressive accounting experience, including Big 4 and public company experience</li><li>Deep experience in global pharma/biotech accounting strongly preferred, especially in organizations with commercially launched products</li><li>Proven ability to interpret complex collaboration agreements and contracts from a technical accounting lens</li><li>Ability to leverage company authorized Artificial Intelligence tools to enhance productivity of yourself and the organization.</li><li>Superb attention to detail, strong planning and organization skills, and the ability to multi-task, prioritize and deliver in a fast-paced, dynamic environment.</li></ul><ul><li>Effective communication skills and strong executive presence, including experience presenting to the Audit Committee</li></ul>Madrigal’s Total Rewards strategy is based on a biotech industry peer group comparator and is inclusive of base pay, bonus and equity. Our equity offers meaningful opportunity allowing our employees to share in the success they help create. By aligning individual and company performance, we empower employees to think like owners, giving them a stake in the organization.All employees receive equity, which we believe reinforces our ownership culture. Base salary is determined by several factors including the candidate’s qualifications, skills, education, experience, business needs and market demands. The base salary range for this position is $245,000 - $299,000 per year.#LI-HybridAll full-time employees receive equity, which reinforces our ownership culture and offers meaningful opportunity for our employees to share in the success they help create. By aligning individual and company performance, we empower employees to think like owners, giving them a stake in the organization. Full-time employees are also eligible for comprehensive benefits, including flexible paid time off, medical, dental, vision and life/disability insurance, and 401(k) offerings (i.e., traditional, Roth, and employer match) in accordance with applicable plans. We also offer additional voluntary benefits like supplemental life insurance, legal services, and other offerings. In addition, we offer mental health benefits through our Employee Assistance Program for employees and their family. The company also provides other benefits in accordance with applicable federal, state, and local laws. We are committed to providing reasonable accommodations for individuals with disabilities throughout the hiring process. If you need assistance, please contact HR@madrigalpharma.com. Madrigal is an Equal Opportunity Employer. All employment is decided on the basis of qualifications, merit, and business need. Applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected by applicable federal, state, or local law. Unsolicited resumes from agencies should not be forwarded to Madrigal. Madrigal will not be responsible for any fees arising from the use of resumes through this source. Madrigal will only pay a fee to agencies if a formal agreement between Madrigal and the agency has been established. Applications are being accepted on an ongoing basis and can be submitted through our <a target="_blank" href="https://madrigalpharma.wd501.myworkdayjobs.com/Madrigal">Madrigal Careers</a> site. Please be aware that we have received reports of individuals misrepresenting themselves as Madrigal Pharmaceuticals’ Hiring Managers, seeking to engage with job candidates through fraudulent online advertisements or job posting sites. These unauthorized individuals are using Madrigal’s name and logo in an attempt to solicit up-front fees and obtain personal information from interested job candidates. Please know that Madrigal does not conduct interviews via text or in chat rooms; conduct interviews via Skype, RingCentral or solely via telephone; charge candidates an advance fee of any kind (e.g., fees for purchasing equipment); nor does it offer positions of employment without undergoing a thorough recruiting process. Please also note that any correspondence with regard to employment would come from an authorized madrigalpharma.com email address or from an email address from one of our trusted search firm partners. We are aware that incorrect/fraudulent email addresses, with Madrigal misspelled, have been utilized in these most recent fraud attempts. If you receive unsolicited employment offers from people claiming to work for or on behalf of Madrigal, we recommend that you: do not respond to their questions; do not open any attachments; and do not click on any hyperlinks. Any questions regarding the legitimacy of job-related contacts can be directed to <a target="_blank" href="mailto:HR@madrigalpharma.com">HR@madrigalpharma.com</a>.

Senior Director, Technical Accounting & SEC Reporting

Description

Madrigal Pharmaceuticals

Pipeline